174 related articles for article (PubMed ID: 34507924)
1. Efficacy and Safety of Regimens Used for the Treatment of POEMS Syndrome- A Systematic Review.
Faizan U; Sana MK; Farooqi MS; Hashmi H
Clin Lymphoma Myeloma Leuk; 2022 Jan; 22(1):e26-e33. PubMed ID: 34507924
[TBL] [Abstract][Full Text] [Related]
2. A review of POEMS syndrome.
Dispenzieri A; Buadi FK
Oncology (Williston Park); 2013 Dec; 27(12):1242-50. PubMed ID: 24624542
[TBL] [Abstract][Full Text] [Related]
3. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
Khouri J; Nakashima M; Wong S
JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
[TBL] [Abstract][Full Text] [Related]
4. Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone.
Gao Y; Zhang S; Yang L; Li J; Liu Y; Wang T
Front Immunol; 2021; 12():681360. PubMed ID: 34025681
[TBL] [Abstract][Full Text] [Related]
5. POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2019 Jul; 94(7):812-827. PubMed ID: 31012139
[TBL] [Abstract][Full Text] [Related]
6. POEMS syndrome: complex factors contributing to a delayed diagnosis.
Robey RC; Campus C; Ringuette B; Shumate M
BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26621905
[TBL] [Abstract][Full Text] [Related]
7. Polyneuropathy, organomegaly, endocrinopathy, monoclonal band, and skin (POEMS) changes syndrome presenting with a pseudosensory level: a case report.
Paranavitane S; Gooneratne L; Chang T
J Med Case Rep; 2019 Dec; 13(1):384. PubMed ID: 31878962
[TBL] [Abstract][Full Text] [Related]
8. Atypical polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes syndrome without polyneuropathy: A case report.
Li Q; Xu F; Duan JF; Tang YF
Medicine (Baltimore); 2020 Jul; 99(27):e20812. PubMed ID: 32629667
[TBL] [Abstract][Full Text] [Related]
9. Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Suichi T; Misawa S; Sekiguchi Y; Shibuya K; Nakamura K; Kano H; Aotsuka Y; Otani R; Morooka M; Tsukamoto S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Kuwabara S
Intern Med; 2022; 61(17):2567-2572. PubMed ID: 36047093
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
[TBL] [Abstract][Full Text] [Related]
11. A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.
Li J; Huang XF; Cai QQ; Wang C; Cai H; Zhao H; Zhang L; Cao XX; Gale RP; Zhou DB
Am J Hematol; 2018 Jun; 93(6):803-809. PubMed ID: 29603764
[TBL] [Abstract][Full Text] [Related]
12. An update on the diagnosis and management of the polyneuropathy of POEMS syndrome.
Cerri F; Falzone YM; Riva N; Quattrini A
J Neurol; 2019 Jan; 266(1):258-267. PubMed ID: 30264176
[TBL] [Abstract][Full Text] [Related]
13. Update on the POEMS syndrome.
Kim YR
Blood Res; 2022 Apr; 57(S1):27-31. PubMed ID: 35483922
[TBL] [Abstract][Full Text] [Related]
14. [POEMS syndrome. A report of four cases].
Andresik D; Russo MP
Medicina (B Aires); 2015; 75(5):324-7. PubMed ID: 26502470
[TBL] [Abstract][Full Text] [Related]
15. Thrombosis revealing POEMS syndrome. About a case.
Dumas C; Bienvenu FH; Hicks J; Weber E; Sève P
Ann Biol Clin (Paris); 2020 Apr; 78(2):195-197. PubMed ID: 32162605
[TBL] [Abstract][Full Text] [Related]
16. [POEMS syndrome: a review of the literature].
Méndez-Herrera CR; Cordoví-Rodríguez D
Rev Neurol; 2011 Jul; 53(1):44-50. PubMed ID: 21678324
[TBL] [Abstract][Full Text] [Related]
17. [Progress in Treatment of POEMS Syndrome--Review].
Fan WJ; Wu T; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1225-1229. PubMed ID: 30111435
[TBL] [Abstract][Full Text] [Related]
18. POEMS Syndrome Showing Left Ventricular Dysfunction and Extracellular Edema Assessed by Cardiac Magnetic Resonance Imaging.
Takahashi Y; Iwano H; Nakano I; Fukushima A; Naya M; Shimizu A; Matsuno Y; Oyama-Manabe N; Anzai T
Intern Med; 2019 Sep; 58(17):2539-2543. PubMed ID: 31118405
[TBL] [Abstract][Full Text] [Related]
19. Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion.
Oyama T; Taoka K; Chiba A; Masamoto Y; Ikemura M; Honda A; Maki H; Kurokawa M
Int J Hematol; 2023 Mar; 117(3):463-467. PubMed ID: 36202948
[TBL] [Abstract][Full Text] [Related]
20. [POEMS syndrome: Diagnosis, stratification, treatments].
Talbot A; Jaccard A; Arnulf B
Rev Med Interne; 2021 May; 42(5):320-329. PubMed ID: 33678446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
